Anthera Pharmaceuticals Cash Conversion Cycle (Quarterly)
View 4,000+ financial data types
Anthera Pharmaceuticals Cash Conversion Cycle (Quarterly) Chart
Anthera Pharmaceuticals Historical Cash Conversion Cycle (Quarterly) DataPro Export Data Date Range:
|Data for this Date Range|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Cash Conversion Cycle
The cash conversion cycle (CCC) is the theoretical amount of time between a company spending cash and receiving cash per each sale, output, unit of operation, etc. It is basically a measure of how long cash is tied up in working capital.
See a sample analysis using the cash conversion cycle.
View Cash Conversion Cycle (Quarterly) for ANTH.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro Gold is only $99 / month.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
ANTH Cash Conversion Cycle (Quarterly) Benchmarks
|Alexion Pharmaceuticals||Go Pro|
PR Newswire 01/30 16:42 ET
Marketwired 01/28 13:07 ET
MarketWatch 12/12 09:23 ET
PR Newswire 11/27 17:00 ET
Street Insider 11/19 10:46 ET
11/19 05:38 ET